Persistence of chromosomal lesions induced in actively proliferating bone marrow cells of the mouse

Mutat Res. 1992 Sep;269(1):119-27. doi: 10.1016/0027-5107(92)90167-z.

Abstract

The persistence of chromosomal lesions induced in vivo by mitomycin C (MMC) was evaluated by cytogenetic analysis of mouse bone marrow cells. Chromosome aberration (CA) and micronucleus (MN) frequencies were estimated at different times after treatment, up to 42 days. The frequency of CA per cell decreased in the first 3 days after treatment, but a secondary peak appeared on the 4th day, followed by a stabilization around 0.03 CA per cell (significantly different from the control value), which persisted up to 17 days. At the next time intervals tested (28 and 42 days), the CA frequency returned to the control level. In disagreement with these data obtained directly on metaphases, the MN frequency, as evaluated in polychromatic erythrocytes, decreased quickly after treatment, reaching the control value on the 5th day. We attempted to enhance the sensitivity of the MN test by using CREST antibodies and indirect immunofluorescence. However, higher proportions of CREST- MN in treated than in control animals were observed only at short time intervals, confirming the results obtained with the conventional MN assay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow / drug effects*
  • Bone Marrow / ultrastructure
  • Chromosome Aberrations*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Micronuclei, Chromosome-Defective*
  • Mitomycin / toxicity*
  • Mutagenicity Tests
  • Time Factors

Substances

  • Mitomycin